Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Williams K, Bastian AR, Feldman RA, Omoruyi E, et al. Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older. J Infect Dis 2020 Apr 22. pii: 5823828. doi: 10.1093.
PMID: 32320465


Privacy Policy